Non-invasive measurement of fibrogenic activity by metabolic labeling of lumican in HCV patients before and after DAA treatment indicates rapid anti-fibrogenic effects after HCV cure

著录项

• 来源
  《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2017年第1期|共2页
• 作者

  Del Bello David P.; Miller Mark; Li Kelvin; Mohammed Hussein; Fitch Mark D.; Decaris Martin; Lee Youngmin A.; Bansal Meena B.; Hellerstein Marc K.; Branch Andrea D.;

  展开▼
• 作者单位

  Icahn Sch Med Mt Sinai Liver Dis New York NY 10029 USA;

  Icahn Sch Med Mt Sinai Liver Dis New York NY 10029 USA;

  Univ Calif Berkeley Nutr Sci &

  Toxicol Berkeley CA 94720 USA;

  Univ Calif Berkeley Nutr Sci &

  Toxicol Berkeley CA 94720 USA;

  Univ Calif Berkeley Nutr Sci &

  Toxicol Berkeley CA 94720 USA;

  KineMed Emeryville CA USA;

  Icahn Sch Med Mt Sinai Liver Dis New York NY 10029 USA;

  Icahn Sch Med Mt Sinai Liver Dis New York NY 10029 USA;

  Univ Calif Berkeley Nutr Sci &

  Toxicol Berkeley CA 94720 USA;

  Icahn Sch Med Mt Sinai Liver Dis New York NY 10029 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 消化系及腹部疾病;
• 关键词